Articles with "fnb" as a keyword



Photo from wikipedia

EUS-guided fine-needle biopsy versus fine-needle aspiration in the diagnosis of subepithelial lesions: a large multicenter study.

Sign Up to like & get
recommendations!
Published in 2020 at "Gastrointestinal endoscopy"

DOI: 10.1016/j.gie.2020.02.021

Abstract: BACKGROUND AND AIMS Although conventional endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) has previously been considered first-line for sampling subepithelial lesions (SELs), variable accuracy has resulted in increased use of fine-needle biopsy (FNB) to improve diagnostic… read more here.

Keywords: diagnosis; accuracy; eus; fine needle ... See more keywords
Photo from wikipedia

A prospective, head-to-head comparison of 2 EUS-guided liver biopsy needles in vivo.

Sign Up to like & get
recommendations!
Published in 2020 at "Gastrointestinal endoscopy"

DOI: 10.1016/j.gie.2020.09.050

Abstract: BACKGROUND AND AIMS Procedural standardization in endoscopic ultrasound-guided liver biopsy (EUS-LB) is necessary to obtain core biopsy specimens for accurate diagnosis. The objective of this study was to directly compare the diagnostic yield of 2… read more here.

Keywords: head; fork tip; guided liver; liver biopsy ... See more keywords
Photo by sangriasenorial from unsplash

Engineered Fenofibrate as Oxidation-Sensitive Nanoparticles with ROS Scavenging and PPARα-Activating Bioactivity to Ameliorate Nonalcoholic Fatty Liver Disease.

Sign Up to like & get
recommendations!
Published in 2022 at "Molecular pharmaceutics"

DOI: 10.1021/acs.molpharmaceut.2c00549

Abstract: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in western countries and China. Fenofibrate (FNB) can activate peroxisome proliferator-activated receptor α (PPARα) to increase fatty acid oxidation and ameliorate NAFLD. However,… read more here.

Keywords: nonalcoholic fatty; fnb; ppar; fatty liver ... See more keywords
Photo by diana_pole from unsplash

Polyurethane Nanoparticle-Loaded Fenofibrate Exerts Inhibitory Effects on Nonalcoholic Fatty Liver Disease in Mice.

Sign Up to like & get
recommendations!
Published in 2018 at "Molecular pharmaceutics"

DOI: 10.1021/acs.molpharmaceut.8b00548

Abstract: Polyurethane (PU) nanoparticles are potential drug carriers. We aimed to study the in vitro and in vivo efficacy of biodegradable PU nanoparticles loaded with fenofibrate (FNB-PU) on nonalcoholic fatty liver disease (NAFLD). FNB-PU was prepared… read more here.

Keywords: loaded fenofibrate; fatty liver; mice; nonalcoholic fatty ... See more keywords
Photo from wikipedia

The bleeding risk after endoscopic ultrasound-guided puncture of pancreatic masses

Sign Up to like & get
recommendations!
Published in 2020 at "Scandinavian Journal of Gastroenterology"

DOI: 10.1080/00365521.2020.1863458

Abstract: Abstract Background Although EUS-fine-needle aspiration (FNA) is considered to be safe, there are limited studies on adverse events of fine-needle biopsy (FNB). Aim To compare the bleeding rate of EUS-FNA and EUS-FNB of solid and… read more here.

Keywords: solid cystic; puncture; pancreatic masses; fnb ... See more keywords
Photo by majesticlukas from unsplash

Comparison of Molding Sand Technology Between Alphaset (APNB) and Furan (FNB)

Sign Up to like & get
recommendations!
Published in 2019 at "Archives of Foundry Engineering"

DOI: 10.24425/afe.2019.129623

Abstract: The paper focuses on investigation of properties of two most widely used self-set sand binder systems APNB and FNB across the Globe, for making molds and cores in foundries to produce castings of different sizes… read more here.

Keywords: dry strength; comparison molding; strength; fnb ... See more keywords
Photo by imsogabriel from unsplash

Development of a Fast and Sensitive UPLC–MS/MS Analytical Methodology for Fenebrutinib Estimation in Human Liver Microsomes: In Vitro and In Silico Metabolic Stability Evaluation

Sign Up to like & get
recommendations!
Published in 2023 at "Separations"

DOI: 10.3390/separations10050302

Abstract: Fenebrutinib (GDC-0853; FNB) is an oral small molecule that was developed by Roche Pharmaceuticals to slow multiple sclerosis progression. FNB is a reversible bruton tyrosine kinase (BTK) inhibitor, which showed the maximum potency of BTK… read more here.

Keywords: fnb; sensitive uplc; methodology; metabolic stability ... See more keywords